Yoshiyo Oguchi

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Randomized Controlled Trial

Bipolar Disorder

Hyaluronic Acid

Top Venues

Neuropsychopharmacology reports

Neuropsychiatric disease and treatment

Journal of medical Internet research

This page only lists publications with an associated author ORCID identifier.

Publications

Yoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Long-acting injectable antipsychotics as maintenance therapy for schizophrenia during the COVID-19 pandemic: A micro-narrative review. Neuropsychopharmacology reports 44 (1) (2024)
Yoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Long-acting injectable antipsychotics as maintenance therapy for schizophrenia during the COVID-19 pandemic: A micro-narrative review. Neuropsychopharmacology reports 44 (1) (2024)
Yoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey. Neuropsychopharmacology reports (2024)
Yoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey. Neuropsychopharmacology reports 44 (2) (2024)
Yoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Long-acting injectable antipsychotics as maintenance therapy for schizophrenia during the COVID-19 pandemic: A micro-narrative review. Neuropsychopharmacology reports (2024)
Yoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey. Neuropsychopharmacology reports 44 (2) (2024)
Yoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Long-acting injectable antipsychotics as maintenance therapy for schizophrenia during the COVID-19 pandemic: A micro-narrative review. Neuropsychopharmacology reports 44 (1) (2024)
Yoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey. Neuropsychopharmacology reports 44 (2) (2024)
Yoshiyo Oguchi
Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter]. Neuropsychiatric disease and treatment 18 (2022)
Yoshiyo Oguchi
Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter]. Neuropsychiatric disease and treatment 18 (2022)
Yoshiyo Oguchi, Atsuo Nakagawa, Hiroki Kocha
A case of postpsychotic depression improved by switching antipsychotic monotherapy. Neuropsychopharmacology reports (2022)
Shigetsugu Nakao, Atsuo Nakagawa, Yoshiyo Oguchi, Dai Mitsuda, Noriko Kato, Yuko Nakagawa, Noriko Takasaki Tamura, Yuka Kudo, Takayuki Abe, Mitsunori Hiyama, Satoru Iwashita, Yutaka Ono, Masaru Mimura
Web-Based Cognitive Behavioral Therapy Blended With Face-to-Face Sessions for Major Depression: Randomized Controlled Trial. Journal of medical Internet research 20 (9) (2018)